Skip to main content
. 2023 Jan 31;24(3):2651. doi: 10.3390/ijms24032651

Table 2.

Classification of EGFR TKIs based on the nature of inhibition of EGFR [10].

Reversible Inhibitors Irreversible Inhibitor
Brigatinib Afatinib
Erlotinib Neratinib
Gefitinib Pyrotinib
Icotinib Almonertinib
Lapatinib Olmutinib
Simotinib Osimertinib
Vandetanib Dacomitinib